AI assistant
Roivant Sciences Ltd. — Director's Dealing 2022
Nov 16, 2022
30587_dirs_2022-11-15_829346c7-966c-40a3-929e-ee2fb2f60885.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2022-11-10
Reporting Person: SVF Investments (UK) Ltd (10% Owner)
Reporting Person: SoftBank Vision Fund L.P. (10% Owner)
Reporting Person: SVF Holdings (UK) LLP (10% Owner)
Reporting Person: SB INVESTMENT ADVISERS (UK) LTD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-10 | Common Shares | S | 4343919 | $4.75 | Disposed | 95031667 | Indirect |
Footnotes
F1: Securities held of record by SVF Investments (UK) Limited ("SVF Investments"). Softbank Vision Fund L.P. is the managing member of SVF Holdings (UK) LLP, which is the sole owner of SVF Investments. SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as the alternative investment fund manager ("AIFM") of SoftBank Vision Fund L.P. SBIA UK is authorized and regulated by the UK Financial Conduct Authority and is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund L.P.'s investments.